Alkermes has acquired 2 companies, including 1 in the last 5 years.
Alkermes’ largest acquisition to date was in 2025, when it acquired Avadel Pharmaceuticals for $2.1B. Alkermes has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (100%).
Connaught House, 1 Burlington Road,
Dublin,
D04 C5Y6
Ireland,
+353 1 772 8000
www.alkermes.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
||
|---|---|---|---|---|---|---|---|---|
| 2025-10-22 |
Avadel Pharmaceuticals · Life Science
Dublin, Ireland · www.avadel.com Avadel Pharmaceuticals is a biopharmaceutical company principally engaged in the development of two unique polymer-based delivery technologies for medical applications. Micropump is a controlled release and taste-masking technology for the oral administration of small molecule drugs. Its Medusa technology is designed to deliver controlled-release formulations of therapeutic proteins. Avadel Pharmaceuticals was founded in 2015 and is based in Dublin, Ireland.
|
2,100
12.4x REVENUE |
Add-on Acquisition |
Alkermes
|
- |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
